Class Action Involving Spectrum Pharmaceuticals, Inc. (SPPI): Contact Robbins LLP if You Incurred Significant Financial Harm from Your Investment in Spectrum Pharmaceuticals, Inc.
December 28, 2022 17:18 ET
|
Robbins LLP
SAN DIEGO, Dec. 28, 2022 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all purchasers of Spectrum Pharmaceuticals, Inc. (NASDAQ:...
Spectrum Pharmaceuticals, Inc. (SPPI) Equity Alert: Contact Robbins LLP for Information About the Class Action Against Spectrum Pharmaceuticals, Inc.
December 14, 2022 17:18 ET
|
Robbins LLP
SAN DIEGO, Dec. 14, 2022 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all purchasers of Spectrum Pharmaceuticals, Inc. (NASDAQ:...
Spectrum Pharmaceuticals, Inc. (SPPI) Shareholder Alert: Robbins LLP Reminds Investors of Class Action Against Spectrum Pharmaceuticals, Inc.
December 08, 2022 12:42 ET
|
Robbins LLP
SAN DIEGO, Dec. 08, 2022 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all purchasers of Spectrum Pharmaceuticals, Inc. (NASDAQ:...